The US Food and Drug Administration (FDA) has recently granted approval for interferon-free treatment for those affected with hepatitis C genotype 1. The treatment offers a 12-week IFN-free, all-oral course. h4The Treatment:/h4 The combination of 2-3 direct-acting antiviral agents (DAAs) will be able to result in 90 percent sustained virologic response (SVR) rates mostly in patient with genotype 1 infection. The list includes patients with subtype 1a, ...
via Medindia Health News
More READ 
Lake forest health and fitness http://ift.tt/1wMzfk5
No comments:
Post a Comment